Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acute N-acetylcysteine with inhaled nitric oxide in primary pulmonary hypertension
2009-014534-15Phase 4Active
- Sponsor
- AOU Città della Salute e della Scienza di Torino
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of acetylcysteine in pulmonary arterial hypertension (PAH), sponsored by AOU Città della Salute e della Scienza di Torino. Primary endpoint: Pulmonary vasodilation effect of N-acetylcysteine with inhaled nitric oxide. Started Sep 2009; status: active.
02
Drugs
acetylcysteine
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on 2009-014534-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014534-15.